RO5503781
NP27872
Phase 1 small_molecule completed
Quick answer
RO5503781 for Neoplasms is a Phase 1 program (small_molecule) at Hoffmann-La Roche with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hoffmann-La Roche
- Indication
- Neoplasms
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed